Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Application of the International Prognostic Score of Thrombosis for Essential Thrombocytemia(ET) (IPSET-Thrombosis) in a Cohort of ET Patients: Experience from Gruppo Laziale for Myeloproliferative Ph Negative Neoplasms

Blood (2015) 126 (23): 2821.

https://doi.org/10.1182/blood.V126.23.2821.2821

Published: 2015

Journal Articles

Improved Overall Survival with Gemtuzumab Ozogamicin (GO) Compared with Best Supportive Care (BSC) in Elderly Patients with Untreated Acute Myeloid Leukemia (AML) Not Considered Fit for Intensive Chemotherapy: Final Results from the Randomized Phase III Study (AML-19) of the EORTC and Gimema Leukemia Groups

Blood (2014) 124 (21): 619.

https://doi.org/10.1182/blood.V124.21.619.619

Published: 2014

Journal Articles

Autopsy Analysis On Epidemiology and Site of Involvement Of Invasive Fungal Infections (IFI) In Hematological Malignancies : A Retrospective Study at Hematologic Tertiary Care Department

Anna Chierichini, Francesca Monardo, Barbara Anaclerico, Paola Anticoli Borza, Velia Bongarzoni, Domenico Campagna, Michele Cedrone, Susanna Fenu, Marianna Norata, Francesca Paoloni, Benedetto Ronci, Luciana Annino

Blood (2013) 122 (21): 5589.

https://doi.org/10.1182/blood.V122.21.5589.5589

Published: 2013

Journal Articles

Clinical Follow-up of Patients with Myeloproliferative Neoplasms Presenting Skin Ulcers During Treatment with Hydroxyurea

Blood (2011) 118 (21): 5157.

https://doi.org/10.1182/blood.V118.21.5157.5157

Published: 2011

Journal Articles

Iron Chelation Therapy with Deferasirox In Transfusion Dependent Myelodysplastic Syndrome Patients. Preliminary Report From the Prospective MDS0306 GIMEMA Trial

Blood (2010) 116 (21): 2928.

https://doi.org/10.1182/blood.V116.21.2928.2928

Published: 2010

Journal Articles

Skin Toxicity of Hydroxyurea In Ph- Myeloproliferative Neoplasms: Incidence and Clinical Features

Roberto Latagliata, MD, Michele Cedrone, Nicoletta Villivà, Massimo Breccia, Barbara Anaclerico, Paola Volpicelli, Antonella Ferretti, Stefano Felici, Enrico Montefusco, Elisabetta Abruzzese, Antonio Spadea, Francesca Spirito, Ettore Cotroneo, Marianna De Muro, Luciana Annino, MD, Giuseppe Cimino, MD, Giuliana Alimena, Marco Montanaro, Alessandro Andriani

Blood (2010) 116 (21): 3077.

https://doi.org/10.1182/blood.V116.21.3077.3077

Published: 2010

Journal Articles

Hepatitis B Virus (HBV) Reactivation In Anti-HB Core Antigen (anti-HBc) Positive Patients with Hematological Malignancies: A Prospective Multicenter Study

Blood (2010) 116 (21): 4911.

https://doi.org/10.1182/blood.V116.21.4911.4911

Published: 2010

Journal Articles

Temsirolimus, An mTOR Inhibitor, In Combination with Low-Dose Clofarabine in Older Patients with Advanced Acute Myeloid Leukemia: Results of a Phase 2 GIMEMA Study (AML-1107)

Sergio Amadori, MD, Adriano Venditti, MD, Emanuele Ammatuna, MD, Alberto M. Martelli, MD, Giovanna Meloni, MD, Fabrizio Pane, MD, Giovanni Martinelli, MD, Monia Lunghi, Livio Pagano, MD, Daniela Cilloni, MD, PhD, Vittorio Rizzoli, Francesco Di Raimondo, MD, Claudio Fozza, MD, Luciana Annino, MD, Alfonso Piciocchi, Edoardo La Sala, Paola Fazi, MD, Marco Vignetti, MD

Blood (2010) 116 (21): 510.

https://doi.org/10.1182/blood.V116.21.510.510

Published: 2010

Journal Articles

Melphalan 200 mg/m 2 versus melphalan 100 mg/m 2 in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study

Blood (2010) 115 (10): 1873–1879.

https://doi.org/10.1182/blood-2009-09-241737

Published: 2010

Journal Articles

“An Intention-to-Treat Analysis of Rome Transplant Network Policy for Alternative Donor Search in Patients Lacking a HLA Matched Related donor”.

Blood (2009) 114 (22): 1195.

https://doi.org/10.1182/blood.V114.22.1195.1195

Published: 2009

Journal Articles

Post Tandem Autologous Stem Cell Transplant Maintenance Therapy with Bortezomib Improves Remission Duration and Quality of Response in Multiple Myeloma Patients.

Rosa Greco, MD, Benedetto Ronci, MD, Barbara Anaclerico, MD, Velia Bongarzoni, MD, Fulvio Pauselli, MD, Piero Iacovino, MD, Francesca Monardo, MD, Giuseppe Avvisati, MD, Luciana Annino, MD

Blood (2009) 114 (22): 4939.

https://doi.org/10.1182/blood.V114.22.4939.4939

Published: 2009

Journal Articles

Treatment of Adolescents and Young Adults with Acute Lymphoblastic Leukemia (ALL): An Update of the GIMEMA Experience.

Luciana Annino, Marco Vignetti, Francesca Paola Paoloni, Anna Maria Testi, Giovanna Meloni, Giorgina Specchia, Giuseppe Fioritoni, Felicetto Ferrara, Nicola Cantore, Francesco Di Raimondo, Francesco Fabbiano, Andrea Camera, MD, Enrica Morra, MD, Pietro Leoni, Paola Fazi, Robert Foa, Franco Mandelli, Sergio Amadori, M.D.

Blood (2009) 114 (22): 3097.

https://doi.org/10.1182/blood.V114.22.3097.3097

Published: 2009

Journal Articles

Rituximab + IEV/MINE Second Line Approach in Relapsed/Refractory Non Hodgkin Lymphoma (NHL): Efficacy and Safety

Velia Bongarzoni, MD, Barbara Anaclerico, MD, Paola Anticoli Borza, MD, Michele Cedrone, MD, Anna Chierichini, MD, Susanna Fenu, MD, Benedetto Ronci, MD, Mariangela Vittori, Maria Cantonetti, MD, Maria Concetta Petti, MD, Luciana Annino, MD

Blood (2008) 112 (11): 4954.

https://doi.org/10.1182/blood.V112.11.4954.4954

Published: 2008

Journal Articles

Standard Versus High Dose Lenograstim in Adults with Hematological Malignancies for Peripheral Blood Progenitor Cell Mobilization: Results of a Retrospective Study on Behalf of Rome Transplant Network.

Azzurra Anna Romeo, Anna Chierichini, Diana Giannarelli, Alessandra Spagnoli, Barbara Anaclerico, Mariangela Vittori, Michele Vacca, Maria Gozzer, Antonio Spadea, MD, PhD, Luciana Annino, Maria Concetta Petti, Andrea Mengarelli, William Arcese, MD

Blood (2008) 112 (11): 2302.

https://doi.org/10.1182/blood.V112.11.2302.2302

Published: 2008

Journal Articles

Darbepoietin in Autologous Peripheral Blood Stem Cell Transplantation (ASCT): A Pilot Study.

Anna Chierichini, MD, Barbara Anaclerico, MD, Paola Anticoli Borza, MD, Susanna Fenu, MD, Carolina Nobile, MD, Michele Cedrone, MD, Velia Bongarzoni, MD, Maurizio Bartolini, MD, Benedetto Ronci, MD, Luciana Annino, MD

Blood (2007) 110 (11): 5101.

https://doi.org/10.1182/blood.V110.11.5101.5101

Published: 2007

Journal Articles

Treatment with Sequential Valproic Acid (VPA) +/− Low Doses All Trans Retinoic Acid (LoATRA) and Low Doses Ara-C (LoDAC) for “De Novo” or Relapsed Acute Myeloid Leukaemia (AML).

Susanna Fenu, MD, Clara Nervi, Carolina Nobile, MD, Anna Chierichini, MD, Paola Anticoli Borza, MD, Barbara Anaclerico, MD, Velia Bongarzoni, MD, Loredana Bove, MD, Stefania Cortese, MD, Fulivio Pauselli, MD, Carla Tozzi, MD, Su Ellen Vignetti, MD, Giuseppe G. Cimino, Luciana Annino, MD

Blood (2007) 110 (11): 4362.

https://doi.org/10.1182/blood.V110.11.4362.4362

Published: 2007

Journal Articles

Protein Expression of p15 and p21 Plays an Unfavorable Prognostic Role in Adult Acute Lymphoblastic Leukemia (ALL) Patients Independently of Their Gene Promoter Methylation Status.

Blood (2007) 110 (11): 2802.

https://doi.org/10.1182/blood.V110.11.2802.2802

Published: 2007

Journal Articles

Safety and Tolerability of Intrathecal Liposomal Cytarabine during CNS Prophylaxis in Patients with Non Hodgkin Lymphoma and Acute Lymphoblastic Leukemia.

Luciana Annino, MD, Barbara Anaclerico, MD, Giulia Benevolo, MD, Nicola Cascavilla, MD, Michele Cimminiello, MD, Matteo Dell’Olio, MD, Alfredo Gagliardi, MD, Giulio Giordano, MD, Eustachio Miraglia, MD, Maurizio Musso, MD, Guido Parvis, MD, Silvia Piano, MD, Chiara Pilatrino, MD, Renato Scalone, MD, Adriano Venditti, MD, Daniela Venditti, MD, Umberto Vitolo, MD, Sergio Storti, MD

Blood (2007) 110 (11): 4460.

https://doi.org/10.1182/blood.V110.11.4460.4460

Published: 2007

Journal Articles

ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia

Blood (2007) 109 (12): 5473–5476.

https://doi.org/10.1182/blood-2006-05-021071

Published: 2007

Includes: Supplemental data

Journal Articles

Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome–positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol

Marco Vignetti, Paola Fazi, Giuseppe Cimino, Giovanni Martinelli, Francesco Di Raimondo, Felicetto Ferrara, Giovanna Meloni, Achille Ambrosetti, Giovanni Quarta, Livio Pagano, Giovanna Rege-Cambrin, Loredana Elia, Raffaello Bertieri, Luciana Annino, Robin Foà, Michele Baccarani, Franco Mandelli

Blood (2007) 109 (9): 3676–3678.

https://doi.org/10.1182/blood-2006-10-052746

Published: 2007

Includes: Supplemental data

NARROW

Application of the International Prognostic Score of Thrombosis for Essential Thrombocytemia(ET) (IPSET-Thrombosis) in a Cohort of ET Patients: Experience from Gruppo Laziale for Myeloproliferative Ph Negative Neoplasms

Autopsy Analysis On Epidemiology and Site of Involvement Of Invasive Fungal Infections (IFI) In Hematological Malignancies : A Retrospective Study at Hematologic Tertiary Care Department

Clinical Follow-up of Patients with Myeloproliferative Neoplasms Presenting Skin Ulcers During Treatment with Hydroxyurea

Iron Chelation Therapy with Deferasirox In Transfusion Dependent Myelodysplastic Syndrome Patients. Preliminary Report From the Prospective MDS0306 GIMEMA Trial

Skin Toxicity of Hydroxyurea In Ph- Myeloproliferative Neoplasms: Incidence and Clinical Features

Hepatitis B Virus (HBV) Reactivation In Anti-HB Core Antigen (anti-HBc) Positive Patients with Hematological Malignancies: A Prospective Multicenter Study

Temsirolimus, An mTOR Inhibitor, In Combination with Low-Dose Clofarabine in Older Patients with Advanced Acute Myeloid Leukemia: Results of a Phase 2 GIMEMA Study (AML-1107)

Melphalan 200 mg/m 2 versus melphalan 100 mg/m 2 in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study

“An Intention-to-Treat Analysis of Rome Transplant Network Policy for Alternative Donor Search in Patients Lacking a HLA Matched Related donor”.

Post Tandem Autologous Stem Cell Transplant Maintenance Therapy with Bortezomib Improves Remission Duration and Quality of Response in Multiple Myeloma Patients.

Treatment of Adolescents and Young Adults with Acute Lymphoblastic Leukemia (ALL): An Update of the GIMEMA Experience.

Rituximab + IEV/MINE Second Line Approach in Relapsed/Refractory Non Hodgkin Lymphoma (NHL): Efficacy and Safety

Standard Versus High Dose Lenograstim in Adults with Hematological Malignancies for Peripheral Blood Progenitor Cell Mobilization: Results of a Retrospective Study on Behalf of Rome Transplant Network.

Darbepoietin in Autologous Peripheral Blood Stem Cell Transplantation (ASCT): A Pilot Study.

Treatment with Sequential Valproic Acid (VPA) +/− Low Doses All Trans Retinoic Acid (LoATRA) and Low Doses Ara-C (LoDAC) for “De Novo” or Relapsed Acute Myeloid Leukaemia (AML).

Protein Expression of p15 and p21 Plays an Unfavorable Prognostic Role in Adult Acute Lymphoblastic Leukemia (ALL) Patients Independently of Their Gene Promoter Methylation Status.

Safety and Tolerability of Intrathecal Liposomal Cytarabine during CNS Prophylaxis in Patients with Non Hodgkin Lymphoma and Acute Lymphoblastic Leukemia.

ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia

Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome–positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only